Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

An oligoclonal antibody durably overcomes resistance of lung cancer to third-generation EGFR inhibitors.

Mancini M, Gal H, Gaborit N, Mazzeo L, Romaniello D, Salame TM, Lindzen M, Mahlknecht G, Enuka Y, Burton DG, Roth L, Noronha A, Marrocco I, Adreka D, Altstadter RE, Bousquet E, Downward J, Maraver A, Krizhanovsky V, Yarden Y.

EMBO Mol Med. 2018 Feb;10(2):294-308. doi: 10.15252/emmm.201708076.

2.

Troponin-I enhances and is required for oncogenic overgrowth.

Casas-Tintó S, Maraver A, Serrano M, Ferrús A.

Oncotarget. 2016 Aug 16;7(33):52631-52642. doi: 10.18632/oncotarget.10616.

3.

Targeting γ-secretases protect against angiotensin II-induced cardiac hypertrophy.

Rivera-Torres J, Guzmán-Martínez G, Villa-Bellosta R, Orbe J, González-Gómez C, Serrano M, Díez J, Andrés V, Maraver A.

J Hypertens. 2015 Apr;33(4):843-50; discussion 850. doi: 10.1097/HJH.0000000000000463. Erratum in: J Hypertens. 2015 Aug;33(8):1717.

PMID:
25915889
4.

Bladder cancer and the Notch pathway.

Fernandez-Marcos PJ, Serrano M, Maraver A.

Oncotarget. 2015 Jan 30;6(3):1346-7. No abstract available.

5.

NOTCH pathway inactivation promotes bladder cancer progression.

Maraver A, Fernandez-Marcos PJ, Cash TP, Mendez-Pertuz M, Dueñas M, Maietta P, Martinelli P, Muñoz-Martin M, Martínez-Fernández M, Cañamero M, Roncador G, Martinez-Torrecuadrada JL, Grivas D, de la Pompa JL, Valencia A, Paramio JM, Real FX, Serrano M.

J Clin Invest. 2015 Feb;125(2):824-30. doi: 10.1172/JCI78185. Epub 2015 Jan 9.

6.

Characterization of two distinct lymphoproliferative diseases caused by ectopic expression of the Notch ligand DLL4 on T cells.

Xiong H, Maraver A, Latkowski JA, Henderson T, Schlessinger K, Ding Y, Shen J, Tadokoro CE, Lafaille JJ.

PLoS One. 2013 Dec 27;8(12):e84841. doi: 10.1371/journal.pone.0084841. eCollection 2013.

7.

Programmed cell senescence during mammalian embryonic development.

Muñoz-Espín D, Cañamero M, Maraver A, Gómez-López G, Contreras J, Murillo-Cuesta S, Rodríguez-Baeza A, Varela-Nieto I, Ruberte J, Collado M, Serrano M.

Cell. 2013 Nov 21;155(5):1104-18. doi: 10.1016/j.cell.2013.10.019. Epub 2013 Nov 14.

8.
9.

SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency.

Herranz D, Maraver A, Cañamero M, Gómez-López G, Inglada-Pérez L, Robledo M, Castelblanco E, Matias-Guiu X, Serrano M.

Oncogene. 2013 Aug 22;32(34):4052-6. doi: 10.1038/onc.2012.407. Epub 2012 Sep 17.

PMID:
22986535
10.

Therapeutic effect of γ-secretase inhibition in KrasG12V-driven non-small cell lung carcinoma by derepression of DUSP1 and inhibition of ERK.

Maraver A, Fernández-Marcos PJ, Herranz D, Muñoz-Martin M, Gomez-Lopez G, Cañamero M, Mulero F, Megías D, Sanchez-Carbayo M, Shen J, Sanchez-Cespedes M, Palomero T, Ferrando A, Serrano M.

Cancer Cell. 2012 Aug 14;22(2):222-34. doi: 10.1016/j.ccr.2012.06.014.

11.

EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours.

Bornachea O, Santos M, Martínez-Cruz AB, García-Escudero R, Dueñas M, Costa C, Segrelles C, Lorz C, Buitrago A, Saiz-Ladera C, Agirre X, Grande T, Paradela B, Maraver A, Ariza JM, Prosper F, Serrano M, Sánchez-Céspedes M, Paramio JM.

Sci Rep. 2012;2:434. doi: 10.1038/srep00434. Epub 2012 May 31.

12.

Anti-aging activity of the Ink4/Arf locus.

Matheu A, Maraver A, Collado M, Garcia-Cao I, Cañamero M, Borras C, Flores JM, Klatt P, Viña J, Serrano M.

Aging Cell. 2009 Apr;8(2):152-61. doi: 10.1111/j.1474-9726.2009.00458.x.

13.

Telomerase reverse transcriptase delays aging in cancer-resistant mice.

Tomás-Loba A, Flores I, Fernández-Marcos PJ, Cayuela ML, Maraver A, Tejera A, Borrás C, Matheu A, Klatt P, Flores JM, Viña J, Serrano M, Blasco MA.

Cell. 2008 Nov 14;135(4):609-22. doi: 10.1016/j.cell.2008.09.034.

14.

The Arf/p53 pathway in cancer and aging.

Matheu A, Maraver A, Serrano M.

Cancer Res. 2008 Aug 1;68(15):6031-4. doi: 10.1158/0008-5472.CAN-07-6851. Review.

15.

Delayed ageing through damage protection by the Arf/p53 pathway.

Matheu A, Maraver A, Klatt P, Flores I, Garcia-Cao I, Borras C, Flores JM, Viña J, Blasco MA, Serrano M.

Nature. 2007 Jul 19;448(7151):375-9.

PMID:
17637672
16.

Effect of presenilins in the apoptosis of thymocytes and homeostasis of CD8+ T cells.

Maraver A, Tadokoro CE, Badura ML, Shen J, Serrano M, Lafaille JJ.

Blood. 2007 Nov 1;110(9):3218-25. Epub 2007 Jul 12.

17.

Regulatory T cells inhibit stable contacts between CD4+ T cells and dendritic cells in vivo.

Tadokoro CE, Shakhar G, Shen S, Ding Y, Lino AC, Maraver A, Lafaille JJ, Dustin ML.

J Exp Med. 2006 Mar 20;203(3):505-11. Epub 2006 Mar 13.

18.
19.

The oligomerization domain of VP3, the scaffolding protein of infectious bursal disease virus, plays a critical role in capsid assembly.

Maraver A, Oña A, Abaitua F, González D, Clemente R, Ruiz-Díaz JA, Castón JR, Pazos F, Rodriguez JF.

J Virol. 2003 Jun;77(11):6438-49.

20.
21.

[Duodenal pseudolipomatosis].

Pallarés Manrique H, Lara C, Maraver A, Talavera A, Ramos JL.

Rev Esp Enferm Dig. 2002 Jan;94(1):42-3. Spanish. No abstract available.

PMID:
12073670
22.

C terminus of infectious bursal disease virus major capsid protein VP2 is involved in definition of the T number for capsid assembly.

Castón JR, Martínez-Torrecuadrada JL, Maraver A, Lombardo E, Rodríguez JF, Casal JI, Carrascosa JL.

J Virol. 2001 Nov;75(22):10815-28.

23.

VP5, the nonstructural polypeptide of infectious bursal disease virus, accumulates within the host plasma membrane and induces cell lysis.

Lombardo E, Maraver A, Espinosa I, Fernández-Arias A, Rodriguez JF.

Virology. 2000 Nov 25;277(2):345-57.

24.

VP1, the putative RNA-dependent RNA polymerase of infectious bursal disease virus, forms complexes with the capsid protein VP3, leading to efficient encapsidation into virus-like particles.

Lombardo E, Maraver A, Castón JR, Rivera J, Fernández-Arias A, Serrano A, Carrascosa JL, Rodriguez JF.

J Virol. 1999 Aug;73(8):6973-83.

25.

Hereditary angioedema: an infrequent cause of abdominal pain with ascites.

Talavera A, Larraona JL, Ramos JL, López T, Maraver A, Arias J, Barrios A.

Am J Gastroenterol. 1995 Mar;90(3):471-4.

PMID:
7872288

Supplemental Content

Loading ...
Support Center